This content aligns with Goal 3: Good Health and Wellbeing by discussing the medical applications and limitations of five US Food and Drug Administration–approved INSTIs for the treatment of HIV/AIDS and preexposure prophylaxis for HIV-1.
This content aligns with Goal 3: Good Health and Wellbeing by discussing 310 tiglianes reported during 1967–2022, including the mechanisms of action of tiglianes against HIV and discusses the anti-HIV structure–activity relationship of certain tiglianes.
PHQ-8 could be used for screening and severity assesment of depressive symptoms at the European level.
This Health Policy paper supports SDGs 2, 3, and 13, by identifying and examining the debates that arose from the publication of the EAT–Lancet Commission, systematically examining how research has been directly influenced by the Commission, and synthesising identified research gaps to build a research agenda for healthy and sustainable food systems.
Background: Over the past three decades, the prevalence of adolescent emotional problems (ie, anxiety and depression) has risen.
Background: Few studies have evaluated postnatal depression before and during the Covid-19 pandemic using comparable data across time.
Background: The role of alcohol use in the development of depression is unclear.
This content aligns with Goal 3: Good Health and Wellbeing by discussing the shifting epidemiology and current management of ESKD in people living with HIV.
Elsevier,

Brain Responses to Auditory Mismatch and Novelty Detection
Predictive Coding from Cocktail Parties to Auditory-Related Disorders
2023, Pages 221-269

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the differences between low- and high-functioning ASD and age dependence of ERP findings in ASD, ADHD, and dyslexia; the effects of language impairment; and the role of ERPs in diagnosing between ASD and ADHD.

Pages